Ribometrix
Ribometrix is a drug-discovery company leading a new paradigm in small molecule therapeutics that modulate RNA biology.
Our industry-leading drug discovery platform enables us to leverage proprietary RNA structure determination, state-of-the-art RNA tools and technologies, and complementary AI/ML capabilities to directly target and modulate RNA biology.
We employ two independent but related strategies to develop small molecule therapeutics:
- direct targeting of complex RNA structures, and
- disrupting RNA/RNA-binding protein interactions.
We believe our commitment to this new paradigm will deliver innovative new therapies to patients.
Our main operations are located in the heart of Research Triangle Park in Durham, North Carolina.
